Sector ratings Pharmaron Beijing Co., Ltd.

Equities

End-of-day quote Shenzhen S.E. Other stock markets 2026-01-09			5-day change	1st Jan Change
31.59 ^CNY	+1.31%		+11.12%	+11.12%

Dec. 18	Pharmaron Beijing Co., Ltd. Announces Election of Mr. Li Shing Chung Gilbert as Employee Representative Director Effective December 18, 2025	CI
25-10-28	Pharmaron Beijing Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
PHARMARON BEIJING CO., LTD.	7.56B		AA
LONZA GROUP AG	48.5B		AAA
IQVIA HOLDINGS INC.	41.28B		AAA
BEONE MEDICINES AG	37.39B		-
CELLTRION, INC.	32.52B		A
REVOLUTION MEDICINES, INC.	22.94B	-	B	-		-
REGENCELL BIOSCIENCE HOLDINGS LIMITED	22.64B	-	-	-	-	-	-	-
MEDPACE HOLDINGS, INC.	16.76B		BBB
EUROFINS SCIENTIFIC SE	14.24B		AA
ICON PUBLIC LIMITED COMPANY	13.85B		AA
IONIS PHARMACEUTICALS, INC.	13.01B	-	A	-		-
ASCENDIS PHARMA A/S	12.46B	-	-	-		-
TEMPUS AI, INC.	11.79B	-	A	-		-
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	10.87B		A
BIO-TECHNE CORPORATION	10.24B		A
QIAGEN N.V.	9.95B		AAA
ABIVAX	8.96B	-	BBB	-		-
BLUEPRINT MEDICINES CORPORATION	8.38B	-	BB	-		-	-	-
PRAXIS PRECISION MEDICINES, INC.	7.91B	-	B	-		-
HANGZHOU TIGERMED CONSULTING CO., LTD	7.12B		AAA
Average	17.92B		AA
Weighted average by Cap.			AA